CPASS MDT: Medicinal Cannabis + Oncology. Pt 1: Theory
MDT Episode 2. Oncology + Cannabis. Part 1: Theory *A separate link is required to register for part 2.
Date and time
Location
Online
Refund Policy
About this event
CPASS presents a new groundbreaking Multi-Disciplinary Team (MDT) webinar series on medicinal cannabis. Theory & real-world case studies.
Episode 2: Cannabis + Oncology
Part 1: Theory of cannabis + oncology featuring
Registered Nurse's <->
Eleanor Owen-Jones RN DPSN MSc Clinical Research &
Megan O'Rahilly RN CNS Upper GI Oncology in conversation with
Specialist Consultants <->
Dr Matt Brown MD (Res) FRCA FFPMRCA MRCS & Dr Charlotte Fribbens.
*Please note, a separate link is required to register for part 2; MDT Case Study, April 12th, 2021.
<-> <-> <->
Over the course of 2021, medical leaders from a multitude of disciplines will come together to provide world-class education on medicinal cannabis for UK registered nurses and healthcare professionals.
Each event, led by nurses, will be structured into 2 parts; the theory behind the benefits of cannabis medicines within key areas of medicine, and an MDT demonstrating how the theory is put into practice.
Each broadcasted session will feature a Specialist Consultant, Nurse, GP and Pharmacist working within the medicinal cannabis sector in the UK. Their discussion will illustrate real-world case studies within each of the following areas; pain, mental health, neurology, palliative care & oncology and women’s health.
This approach is a pioneering welcome for health practitioners in the UK, as medicinal cannabis education expands to reach a more inclusive sector of frontline medics.
While the aim of the webinar series is to provide practical education for health professionals about the real-life clinical applications of cannabis medicines, the sessions will be equally valuable for patients, care-givers, or indeed anyone with an interest in deepening their understanding of how CBMPs can bring symptom relief in a select variety of indications.
The series will end with an event exploring the stigma surrounding these new cannabis medicines and how healthcare professionals may gain a better understanding of them in order to better care for our patients.
ABOUT
Eleanor Owen Jones RN DPSN MSc Clinical Research
Eleanor is a Registered Nurse with over 10 years of experience in the NHS predominantly Clinical Research in Palliative Medicine. She has also worked on the Sativex Studies at Christie Hospital in Manchester. Currently, Eleanor is the Medical Science Lead for Spectrum Therapeutics where Eleanor is in charge of education and research support for medicinal cannabis with Health Care Professionals. Eleanor's background comprises a BSc in Physiology, DPSN in Adult Nursing, and a Masters in Clinical Research.
Megan O’Rahilly RN CNS Upper GI Oncology
Megan is a Registered Nurse working within the NHS at Kingston Hospital NHS Foundation Trust currently working as a Clinical Nurse Specialist in Upper GI Oncology with a focus on palliative care patients. Megan has spent the past five years specialising in Oncology and has worked on chemotherapy units, clinical trials and an acute oncology unit. Pain and symptom control is a core part of Megan’s current role. Patients ask if there is a role for cannabis within their care and often as their nurse specialist she will be the first person they ask. “I believe it is my responsibility to advocate for these patients and help support research into cannabis so we as practitioners can better advise and ensure people are getting the best care possible. “
Dr Matt Brown MD (Res) FRCA FFPMRCA MRCS
Matt Brown is a consultant in pain medicine at the Royal Marsden Hospital, and Honorary Associate Faculty of the Institute of Cancer Research where he supervises doctoral students. He trained at King’s College London, winning the War Memorial and Wolfson Foundation Scholarships and graduating with distinction.
His clinical training in pain medicine was conducted at The Royal National Orthopaedic Hospital and the National Hospital for Neurology and Neurosurgery. Matt fulfilled his long-term interest in clinical research by gaining a National Institute for Health Research’s Academic Clinical Fellowship. This enabled him to conduct novel, award-winning research into pain at both Imperial College and King’s College, London. Subsequently, Matt completed a Doctorate in Medicine at the Institute of Cancer Research (becoming the first anaesthetist in the Institute’s history to do so and winning the Chairman’s Prize at graduation).
Matt has published and lectured widely on the subject of pain in cancer. His research interests include pain in cancer survivors and the role of cannabis-based medicinal products (CBMP) may play in this area.
Links to papers available on Dr Brown’s website www.cancerpainlondon.com
Dr Charlotte Fribbens
Dr Charlotte Fribbens is a Medical Oncology Consultant at The Royal Marsden Hospital, specialising in Gastrointestinal Cancers and Acute Oncology. She trained at Imperial College and undertook a higher research degree at the Institute of Cancer Research. Her interests include clinical trials and translational research in gastrointestinal cancers and research into the use of cannabis-based medicine in patients with cancer-related pain.
CPASS:
Cannabis Patient Advocacy & Support Services (CPASS) is a cross-sector collaborative initiative providing education, advocacy and support for patients and healthcare professionals for cannabis-based treatments within the patient’s care pathway. The Nurse’s Arm of CPASS, launched in November 2019 at the Royal College of Nursing in London, is in founding partnership with former Health Minister and MP, Professor Ann Lloyd Keen RN NDN FQNI FRCN FAAN. CPASS mission is to collaborate, advocate, research and educate, empowering frontline healthcare professionals to make an impact on how cannabis-based medicinal products (CBMPs) may feature in the future of healthcare in Britain. It’s Nurse, Midwife and Educator led principal focus is on improving health, clinical outcomes and patient experience, through building nursing and midwifery leadership capacity to make significant improvements to the cannabinoid patient care pathway.
Below, a link to our previous episode on cannabis and pain, the theory with our in house Clinical Nurse Lead, Sophie Hayes RN in presentation with Dr Anthony Ordman.